Most of the compounds have physiologically active properties, and their biological properties are often attributed to the heteroatoms contained in their molecules, and most of these heteroatoms also appear in cyclic structures. A Journal, Inorganica Chimica Acta called Synthesis of potential platinum(II) antitumor complexes: complexes containing bidentate pyridyl and imidazolyl donors, Author is Canty, Allan J.; Stevens, Elizabeth A., which mentions a compound: 15227-42-6, SMILESS is [Cl-][Pt+2]([N]1=CC=CC=C1)([Cl-])[N]2=CC=CC=C2, Molecular C10H10Cl2N2Pt, Formula: C10H10Cl2N2Pt.
PtLCl2 [L = di-2-pyridylmethane, 3,3-bis(2-pyridyl)pentane, 2-(2-pyridyl)imidazole (I), N-methyl-2-(2-pyridyl)imidazole] were prepared and characterized by chem. anal., elec. conductivity, IR spectra, and inhibitory effects on cultures of L1210 mouse leukemia cells. The complex with L = I gave a 50% inhibiting dose similar to that of cis-Pt(NH3)2Cl2 and below the values of the other complexes; this suggests that further tests with tumor-bearing animals is warranted for this I complex with Pt.
There is still a lot of research devoted to this compound(SMILES：[Cl-][Pt+2]([N]1=CC=CC=C1)([Cl-])[N]2=CC=CC=C2)Formula: C10H10Cl2N2Pt, and with the development of science, more effects of this compound(15227-42-6) can be discovered.
Reference:
Tetrahydroisoquinoline – Wikipedia,
1,2,3,4-Tetrahydroisoquinoline | C9H11N – PubChem